Moreover, polymorphisms and mutations in the LRP5 are associated with osteoporosis, impaired glucose, increased risk for obesity, type 2 diabetes mellitus, and other metabolic diseases (7-9,11,12). Here, LRP5 is linked to type 2 diabetes mellitus.